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Background: Nested case–control studies become increasingly popular as they can be very efficient for quantifying
the diagnostic accuracy of costly or invasive tests or (bio)markers. However, they do not allow for direct estimation
of the test’s predictive values or post-test probabilities, let alone for their confidence intervals (CIs). Correct
estimates of the predictive values itself can easily be obtained using a simple correction by the (inverse) sampling
fractions of the cases and controls. But using this correction to estimate the corresponding standard error (SE),
falsely increases the number of patients that are actually studied, yielding too small CIs. We compared different
approaches for estimating the SE and thus CI of predictive values or post-test probabilities of diagnostic test results
in a nested case–control study.
Methods: We created datasets based on a large, previously published diagnostic study on 2 different tests (D-dimer test
and calf difference test) with a nested case–control design. We compared six different approaches; the approaches were:
1. the standard formula for the SE of a proportion, 2. adaptation of the standard formula with the sampling fraction, 3. A
bootstrap procedure, 4. A approach, which uses the sensitivity, the specificity and the prevalence, 5. Weighted logistic
regression, and 6. Approach 4 on the log odds scale. The approaches were compared with respect to coverage of the CI
and CI-width.
Results: The bootstrap procedure (approach 3) showed good coverage and relatively small CI widths. Approaches 4
and 6 showed some undercoverage, particularly for the D-dimer test with frequent positive results (positive results
around 70%). Approaches 1, 2 and 5 showed clear overcoverage at low prevalences of 0.05 and 0.1 in the cohorts
for all case–control ratios.
Conclusion: The results from our study suggest that a bootstrap procedure is necessary to assess the
confidence interval for the predictive values or post-test probabilities of diagnostic tests results in studies
using a nested case–control design.Background
An essential step in the evaluation process of a (new)
diagnostic test is to assess the diagnostic accuracy mea-
sures [1-4]. Traditionally the sensitivity and specificity are
studied but another important measure is the predictive
value, i.e. the absolute probability that the disease is
present or absent given the test result, so-called post-test
probability [5]. Typically, diagnostic accuracy studies use* Correspondence: b.vanzaane@umcutrecht.nl
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distribution, and reproduction in any mediuma cross-sectional design in a series or cohort of patients
that is defined by the suspicion of the target disease
under study. This suspicion is usually defined by the pre-
sented symptoms or signs. All patients then undergo the
index (e.g. new) tests and subsequently the prevailing
reference test or standard [5,6]. Subsequently the predic-
tive values or post-test probabilities of the test results, as
well as the sensitivity and specificity can be estimated.
An efficient alternative for this full cohort design is
the nested case–control design, in which the controls
and cases are sampled from a pre-defined cohort [5-8].
This design is particularly advantageous for diagnostic
research purposes when the prevalence of the disease istral Ltd. This is an Open Access article distributed under the terms of the
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form, and when using stored (e.g. biological) material
from existing cohorts or biobanks [5-7,9]. Limitations,
strengths and rationale of the nested case–control de-
sign are extensively discussed in the literature, mostly
for etiologic research [8,10,11], but also recently for the
evaluation of diagnostic tests [5,6,9].
As an important aim in diagnostic research is to esti-
mate the absolute probability of having the disease given
test results (predictive values or post-test probability),
the nested character of the design in a cohort with
known size is essential. In non-nested or regular case–
control studies, controls are sampled from a source
population with unknown size. The prevalence of the
disease and hence the predictive values can thus not
simply be estimated [5,6]. Only relative probabilities, like
the odds ratio, can directly be estimated. However, abso-
lute disease probabilities can be estimated, if cases and
controls are sampled from an existing, pre-defined co-
hort, by weighing with the inverse sampling fraction [5].
For example, consider a full-cohort approach in which
the index test result and reference test results are
assessed for all patients. Say the index test is an expen-
sive dichotomous biomarker (genomic) measurement re-
quiring human material that is frozen for all cohort
members in a biobank. The positive predictive value
(PPV) of the marker result is aaþb , and the negative pre-
dictive value (NPV) dcþd (Figure 1, Table A, see legend of
Figure 1 for explanation of variable names).
In a nested case–control design, one samples from the
full cohort (commonly) the human material of allA) Full study population, in general           
Disease
+ -
Test + a b a+b
Result - c d c+d
a+c b+d N
C) Nested case-control sample,
     in general    
Disease
+ -
Test + a b1 a+b1
Result - c d1 c+d1
a+c b1+d1 N1
Figure 1 Theoretical example of case–control sample, nested in a coh
positive, B = false positive, C = false negative, D = true negative, N = numsubjects with a positive reference test (cases), but only a
fraction (see cell b1 and d1, Figure 1, Table C) of those
with a negative reference test (controls). The expensive
index test is thus only retrieved or measured in the
human material of the sampled cases and controls.
In contrast to the typical case–control design, in this
nested design the absolute disease probabilities can be
calculated by weighing the denominator with the inverse





; with sampling fraction b1þd1bþd
(Figure 1, Table C). For example, the PPV and NPV from
the full study are 30/(30+100)=0.23 and 300/(10+300)=
0.97 (Figure 1, Table B). Applying the approaches for
the nested case–control sample with only 10% of all
non-diseased patients yields the same results. Sam-
pling fraction = (10+30)/(100+300)=0.1, PPV=30/(30+
(10 • 10)) = 0.23, NPV = (30 • 10)/(10+(30 • 10))=0.97
(Figure 1, Table D).
However, the estimation of the standard error (SE) of
the predictive values derived from a nested case–control
diagnostic accuracy study is not at all straightforward.






, where π is the proportion, here
predictive value or absolute disease probability, and n
the number of patients, the question is which value for n
to use. The actual observed (measured) number of cases
and controls does not correspond to the estimated pro-
portion (too low). But simply using the upwardly cor-
rected number of controls and (if also sampled) cases,B) Full study population, example
Disease
+ -
Test + 30 100 130
Result - 10 300 310
40 400 440
D) Nested case-control sample,
    example 
Disease
+ -
Test + 30 10 40
Result - 10 30 40
40 40 80
ort with known size and prevalence of the disease. (A = true
ber of patients).
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yielding too small SE’s. Clearly, modifications have to be
made to the standard formulas, to estimate the correct
SE of the predicted values of a diagnostic index test from
a nested case–control study.
Recently Mercaldo and colleagues published a ap-
proach to estimate the SE of predictive values for a
case–control approach [12].We compared the approach
proposed by Mercaldo with five other approaches
using simulated datasets based on an empirical pub-
lished diagnostic study among patients suspected of
deep venous thrombosis. We studied several clinically




We used data from a published cross-sectional diagnos-
tic study that collected a cohort of 2086 adult patients
suspected of deep vein thrombosis (DVT) in primary
care [13,14]. In brief, the general practitioners systema-
tically documented information on patient history and
physical examination. Physical examination included
swelling of the affected limb and difference in circumfer-
ence of the calves calculated as the circumference (in
centimeters) of affected limb minus circumference of
unaffected limb, further referred to as calf difference
test. The calf-difference was considered to be abnormal
if the difference in circumference between the legs was
more then 3 cm. Subsequently, all patients underwent
D-dimer testing.
Depending on the hospital to which the patient was re-

























Figure 2 Flow-chart of the sampling process of the nested case–cont
prevalence in the source population of 0.05, 0.1 and 0.2. “n” in the nested c
controls) size across 1000 samples.Biomerieux, France) or the latex assay approach
(Tinaquant, Roche, Germany) was used to determine
the D-dimer level. The test was considered abnormal if
the latex assay yielded a D-dimer level ≥400 ng/mL
(Tinaquant, Roche, Germany) or ≥500 ng/mL for the
ELISA assay (VIDAS, Biomerieux, France) [15]. Values
were dichotomized: normal versus abnormal. In the present
approachological study, we focus on the calf difference and
D-dimer test as index tests. Presence of DVT (yes/no) was
assessed in all patients with the reference test (repeated
compression ultrasonography of the symptomatic leg).
Nested case–control samples
We first studied a source population based on the ori-
ginal data set (Figure 2, line 1), with a prevalence of
DVT of 0.1 (140 cases, 1260 controls), reflecting a
relatively rare disease situation that commonly directs
case–control studies (Figure 2, line 2). The diagnostic
accuracy parameters estimated for this source population
serve as the commonly unknown true parameter values
(see below and Table 1). Subsequently, we mimicked a
cross-sectional cohort study of the same size as the
source population, i.e. 1400 patients that were drawn
with replacement from our source population (cohort,
Figure 2, line 3).
A nested case–control sample was then created from
the cohort (Figure 2, line 4). We included all patients
with DVT (cases) from the corresponding cohort in the
nested case–control sample, and an equally sized ran-
dom sample from the subjects without DVT (controls):
case–control ratio = 1:1. To prevent too much sampling
errors (random variation), we repeated the above ap-











rol samples. This process was repeated for a deep venous thrombosis
ase–control sample represents the average sample (cases plus
Table 1 Estimates of diagnostic accuracy of the D-dimer
test and the calf-difference test in the source population




PPV* NPV* Sensitivity Specificity DOR Positive test
result (%)
D-dimer test (dichotomous)
0.05 0.07 0.99 0.96 0.32 10.7 69
0.1 0.14 0.99 0.97 0.33 9.2 70
0.2 0.26 0.97 0.96 0.33 11.9 73
Calf-difference test (dichotomous)
0.05 0.09 0.98 0.69 0.65 4.0 37
0.1 0.17 0.95 0.68 0.64 3.1 39
0.2 0.32 0.89 0.67 0.65 3.8 41
* Estimates of PPV and NPV obtained with the weighted formula, with
Mercaldo’s approach and with weighted logistic regression were the same
(PPV = positive predictive value; NPV = negative predictive value,
DOR=Diagnostic Odds Ratio).
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samples. In the 1000 nested case–control samples we
estimated the predictive values of both index tests and
their uncertainty (standard error and 95% CI) using the
six approaches described below. All this was also done
for three other case–control ratios: 2 controls per case
(ratio 1:2); 3 controls per case (1:3); and 4 controls per
case (1:4). The prevalence of the 1000 cohorts was thus
not fixed across the different cohorts, though with a
mean prevalence of 0.1 (95% CI 0.08-0.12). The actual
prevalence of the corresponding cohort was used for all
subsequent calculations in the nested case–control
sample.
Finally, the entire process of creating the 1000 study
cohorts and 1000 corresponding nested-case control
samples (with the four different case–control ratios),
was repeated for a source population (n=1400) with a
DVT prevalence of 0.05 (70 cases) and 0.2 (280 cases).Approaches to estimate the uncertainty of predictive
values of a diagnostic test from a nested case–control
study
We compared six approaches to estimate the 95% CI
of the predictive values obtained from the nested
case–control samples, for the two index tests (D-dimer
test and calf circumference difference). The point esti-
mates of the predictive values were obviously the same
for all six approaches, while the standard error esti-
mates and hence 95% CI could vary. We describe the
approaches for the predictive value of a positive result
(positive predictive value = PPV). They can mutatis
mutandis be applied to the negative predictive value
(NPV). Notations used below, refer to those used inFigure 1 (see legend of Figure 1 for explanation of
variable names).
1. Estimate the standard error of the PPV (SE(PPV))
using the standard formula for the SE of a proportion
with the actually observed number of patients in the
nested case–control sample:








The 95% confidence interval can simply be calculated
as PPV ± 1.96*SE(PPV)Calculating the SE with the ac-
tually observed numbers in the nested case–control
samples (i.e. without correction for the sampling frac-
tion that is used to estimate the correct PPV, using the
upweighting by the samping fraction as shown in
Table 1), agrees to the number of patients actually
measured. However, the proportions in approach (1)
do not correspond to the e stimated (corrected) PPV.
2. Estimate the SE(PPV) using the standard formula for
SE of a proportion with correction for the sampling
fraction in the numerator of approach 1 above, but
not in the denominator:
SE PPVð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
a
aþ 1Sampling f raction•b1 •
1
Sampling f raction•b1
aþ 1Sampling f raction•b1
aþ b1
vuut
The correction is only applied to the numerator as this
reflects the (corrected) PPV estimates. Applying the cor-
rection also to the denominator, would make the SE incor-
rectly too small: a larger number of patients than actually
observed would then be used in the SE estimation.
3. Assess the empirical distribution of the PPV using a
bootstrap procedure. Per nested case–control sample
we drew 1000 bootstrap samples and estimated the
PPV in each bootstrap sample. The PPV values
corresponding to the 2.5 and 97.5 percentiles of the
1000 bootstrap estimates were used as the limits of
the 95% confidence interval.
4. The approach recently described by Mercaldo and
colleagues [12]. This approach uses the prevalence
from the underlying study cohort (not to be confused
with our ‘true’ source population, see above) and the
sensitivity and specificity estimated from the case–
control sample to calculate the correct PPV. Not only
the PPV can be estimated using the sensitivity (Sens) ,
specificity (Spec) and prevalence (p), but also the SE
(PPV):
SE PPVð Þ ¼ p• 1 Specð Þ• 1 pð Þ½ 
2• Sens• 1Sensð Þaþc þ p•Sens• 1 pð Þ½ 2• Spec• 1Specð Þb1þd1
 pÞ4
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logistic regression model with outcome disease
present (y/n) and one covariable (index test result,
positive or negative), with weights for cases and
controls. The model can be written as log odds
(PPV) = log ppv1ppv
 
= α + β ×. With × =1 for a
positive index test result. Each case receives a
weight w(cases) = N1N (rather than simply weight 1)




Sampling fraction. Hence, the sum of the weights
over all sampled subjects equals the total number
of subjects in the nested case–control sample (N1).
This sum equals the effective sample size in the
estimations of the PPV and SE(PPV). Results of the
so weighted regression analysis are the intercept (α)
and the regression coefficient for the index test (β).
The standard error of the logit(PPV) can be
calculated from the covariance matrix SE(logit[PPV]) =ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
variance αð Þp þ variance βð Þ þ 2• covar α; βð Þ The
covariance matrix is estimated with the correct number
of observed (N1) patients, since case and controls were
weighted in the analysis.
6. Use the approach by Mercaldo and colleagues
(approach 3) [12] on the log odds scale. One uses the
sensitivity (Sens) , specificity (Spec) and prevalence
(p) in the known study cohort, to estimate the SE of
the logit(PPV) by:














The PPVs of both index tests were thus calculated
using the weighting approach from Figure 1. We then
estimated the 95% confidence interval of the PPV
using the six approaches above. From the 1000 nested
case–control samples, the average 95% confidence
interval width and the coverage probability were esti-
mated. The narrower the average confidence interval
width, the more precise the estimated predictive value
[16]. The coverage probability is the proportion of the
1000 confidence intervals that included the true PPV
estimated from of the source population. The coverage
should not fall outside two SE’s of the nominal prob-
ability (p) [16]. Nominal p is 0.05 for a 95% confidence
interval, with SE(nominal p) = 0.0069 for a simulation






Sens•pþ 1 Specð Þ• 1ð½the number of repetitions). The corresponding cover-
age ranges from 0.936 – 0.964. If the coverage prob-
ability of the PPV’s falls outside this interval we speak
of “substantial undercoverage” for lower coverage
probability (<0.936), or overcoverage for higher
(>0.964) coverage probability.
The ideal estimation approach has a coverage close to
95% and a small 95% confidence interval of the esti-
mated predictive values.
All analyses were executed for the four case–control
ratios, and for the three different disease prevalence’s in
the source population.
Analyses were performed with R version 2.6.0 [17].
Results
Table 1 shows the accuracy estimates of both index tests
as estimated from the source population. The PPV of
both tests was low and the NPV of both tests was high
as a result of the low prevalence of DVT. For both tests,
the PPV increased and NPV decreased with increasing
prevalence of DVT. The D-dimer test was very sensitive
with limited specificity. The calf difference test was
moderately sensitive and specific. The D-dimer test was
positive in 978 (70%) patients for a DVT prevalence of
0.1. The calf-difference test was positive in 568 (41%)
patients. Changing the prevalence of diseases did not
change the percentage of positive tests. As expected, for
both tests, the sensitivity, specificity and diagnostic odds
ratio were similar for each prevalence. The point esti-
mate for the PPV and NPV obtained with weighted lo-
gistic regression were similar (respectively 0.14 and 0.99)
to those obtained with the standard approach.
Approaches one, two and five showed clear overcoverage
at low prevalences of 0.05 and 0.1 in the cohorts for all
case–control ratios. They showed less overcoverage at a
prevalence of 0.20 and even an undercoverage (Figure 3
and 4, approach 5). Approach three yielded slight over-
coverage for lower case–control ratios (1:1, 1:2) and for
low prevalences (0.05 and 0.01). Approaches four and six
showed undercoverage for higher case–control ratios (1:3,
1:4). Extreme undercoverage was seen at a prevalence of
0.20 (Figure 3 and 4, left panels) for both approach four
and six.
In general, approach one showed the largest confidence
interval width corresponding to the overcoverage, whereas
approach four and six showed very similar and small
widths. Approach three showed slightly larger widths then
approach four and six (Figure 3 and 4, right panels).
Figure 3 For each estimation approach (for details see text) and per deep venous thrombosis prevalence, the plot of positive
predictive value coverage probabilities and 95% confidence interval width per approach for different prevalence’s for the D-dimer test
(1 = Standard formula for obtaining a standard error of a proportion, 2 = as 1st approach but with correction for sampling fraction,
3 = Bootstrap procedure, 4 = Mercaldo and colleagues approach, 5 = Weighted logistic regression, 6 = Logit transformation of
Mercaldo and colleagues approach). Colors/figures represent the different sampling fractions (Black circle = 1 case: 1 control, Red square = 1:2,
Blue diamond = 1:3, Yellow triangle = 1:4). The vertical lines represent the ideal 95% coverage with its confidence interval, i.e. the levels of
acceptability.
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Figure 4 For each estimation approach (for details see text) and per deep venous thrombosis prevalence, the plot of the positive
predictive value coverage probabilities and the 95% confidence interval width, for the calf difference test. 1 = Standard formula for
obtaining a standard error of a proportion, 2 = as 1st approach but with correction for sampling fraction, 3 = Bootstrap procedure, 4 = Mercaldo
and colleagues approach, 5 = Weighted logistic regression, 6 = Logit transformation of Mercaldo and colleagues approach). Colors/figures
represent the different sampling fractions (Black circle = 1 case: 1 control, Red square = 1:2, Blue diamond = 1:3, Yellow triangle = 1:4). The
vertical lines represent the ideal 95% coverage with its confidence interval, i.e. the levels of acceptability.
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We compared six approaches for estimating the confi-
dence intervals of predictive values or post-test probabil-
ities of diagnostic test results when a nested case–control
design is used. using simulations in a large empiricaldiagnostic study, the six approaches were compared in
terms of coverage and the width of the 95% confidence
intervals. Our data show that a bootstrap procedure
(approach 3) seems to be the preferred approach, although
it was only slightly better than the other approaches.
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ticularly for the D-dimer test with frequent positive results
(positive results around 70%). Approaches 1, 2 and 5
showed overcoverage. For a prevalence of 0.2 in the under-
lying cohort and a case–control ratio of 1:4 all approaches
showed substantial undercoverage. In fact a case–control
ratio of 1:4 implies a prevalence of 0.2 in the nested case–
control sample. Hence, one may argue that a full cohort
study is to be preferred, when the disease prevalence in
the cohort is 0.2 or higher. Indeed, case–control studies
are notably advantageous when the prevalence of a disease
in the cohort is rare (i.e. below 0.1).
By applying a nested case–control design in diagnostic
accuracy studies the number of patients undergoing the
index test can be substantially reduced, hereby increas-
ing the efficiency of the particular study [6,8,10,11]. This
becomes more important if the index test comes with
large patient burden, is costly, the disease is rare, and
when stored biological material is used for measuring
new tests, e.g. from proteomics, metabolomics or gen-
omics. Previously it has been shown that by applying a
correction for the sampling fraction precise point esti-
mates of the predictive values can be obtained [5]. We
found that applying a bootstrap procedure to estimate
the confidence intervals around these predictive values,
yields adequate results for the uncertainty in the esti-
mated predictive values. Limitation of this approach can
be that, due to the low numbers, in some of the boot-
strap samples one of the cells of the 2×2 table remains
empty, The latter did not happened in our simulation. If
this happens PPV may be estimated with a continuity
correction for low numbers.
The predictive values obtained with the approach re-
cently discussed by Mercaldo and colleagues were equal
to those derived with the weighted approach from
Figure 1. For the lower prevalence’s (0.05 and 0.10) the
coverage of approaches 4 and 6 was between 0.90 and
0.95 which were similar to those found by Mercaldo and
colleagues themselves [12]. With increasing case–control
ratio and increasing prevalence, the Mercaldo and col-
leagues approach yielded more undercoverage. This
could be due to the fact that in their original paper the
case–control ratio was not explicitly varied, although in
their equation the case–control ratio implicitly has influ-
ence on the SE and hence the confidence interval. Be-
sides the study by Mercaldo and colleagues we are not
aware of any other studies coping with this issue of un-
certainty of predictive values estimated from nested case
control studies.
A limitation of our study could be that we looked at
only one original cohort in our simulations and studied
only two index tests. Although the results for the differ-
ent combinations simulated are alike, it is thinkable that
for other combinations of disease prevalence, cohortsizes, and diagnostic accuracy of the index tests, the
results could slightly differ. We certainly realize that
DVT is not a true rare disease and most diagnostic stud-
ies on DVT are done on a full-cohort and not on a
nested case–control sample. Therefore, we slightly
modified the prevalence in the full cohort to better
mimick the rare-disease situation, which we needed for
our comparisons.
By using a fixed cohort size (n=1400) for the different
prevalence’s, the size of the nested case–control samples
varied (Figure 2). This could have influenced our results
slightly since the SE and the confidence interval depends
on the number of observations. Alternatively one could
use a fixed number of cases in with varying cohort sizes
for different prevalence’s.
Conclusion
Our case-study suggests that in diagnostic accuracy
studies using a nested case–control design, one can
apply a simple bootstrap procedure to obtain a confi-
dence interval for the post-test probabilities or predictive
values of the index test results. For our data-set, the
bootstrap procedure showed the best combination of
coverage and 95% confidence interval width, compared
with the other approaches. Our findings and inferences
can also be applied to nested case control studies that
investigate the predictive values of results from other
kind of tests, for example prognostic tests.
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